Monsenso, a technology firm developing mobile health solutions for mental health based in Copenhagen, announces their partnership with Gen Re, one of the leading companies worldwide in the field of reinsurance.
The partnership aims to grant the insurance sector access to Monsenso’s product mHealth Solution, which is an assisting tool in the prevention, early intervention and treatment of mental illnesses. Thomas Lethenborg, CEO at Monsenso, emphasizes the importance of partnerships for the company:
“Monsenso is looking to build sustainable, long-term partnerships, with the ultimate goal of delivering better care, to more people, at a lower cost”
The technology of mHealth improves patient-engagement, increasing an individual’s desire to play a more active role in their treatment. It enables patients to self-monitor their lifestyle and their symptoms, helping them recover faster from mental illness. Currently it is being used in a clinical capacity in the UK, Denmark, Norway, Sweden, Germany and Australia to support the treatment of a wide range of mental and behavioural disorders.
Joint forces for better solutions to treat mental illness
Monsenso and Gen Re will work jointly on facilitating insurance companies to offer an enhanced service to their customers: By offering the solution, insurers can actively support their customers return to work more quickly, and avoid becoming ill again, an advantage for both, insurers and customers.
“The objective of this partnership is to promote the use of mHealth technology among insurance companies. With this technology, their customers can get better faster by receiving better mental health care, while reducing costs at the same time”, says Thomas Lethenborg.
Having the desire to deliver the best innovative new technology solutions to customers, Gen Re bring their extensive insurance industry knowledge to the partnership, as Jules Constantinou, Regional Manager for Gen Re Life/Health in the UK and Ireland, points out:
“It is important that the life insurance industry embrace new technologies and new processes in order to remain relevant in the lives of customers going forward. Clinical medicine is also evolving and we are very pleased to announce this partnership with Monsenso, which should improve outcomes for insurance claimants who are battling mental illness”